| abstract |
The present invention is a multi-unit dosage form comprising a core, wherein the core comprises a plurality of individual units, each unit comprising a pharmaceutically active ingredient, each unit being a mucoadhesive material The invention relates to a multi-unit dosage form which is coated with and which further comprises an enteric core coating layer. The invention further relates to the use of said multi-unit dosage form in the treatment of inflammatory disorders, in particular of gastrointestinal tract. |